TDOC
Teladoc Health, Inc.
-0.03 (-0.47%)6.40USD877K成交股數1.2B市值–本益比(近四季)0.5股價營收比-4.0%營收年增(近四季)2026-10-28下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 607M-4% | 614M-2% | 642M+0% | 626M-2% | 632M-2% | 629M-5% | 641M-3% | 642M-2% | 646M | 661M | 660M | 652M |
| 營業成本 | 191M | 198M | 197M | 187M | 191M | 197M | 180M | 188M | 195M | 193M | 186M | 191M |
| 毛利 | 416M-6% | 416M-4% | 445M-3% | 439M-3% | 441M-2% | 433M-7% | 461M-3% | 454M-2% | 452M | 467M | 474M | 462M |
| 毛利率 | 68.6% | 67.8% | 69.3% | 70.1% | 69.8% | 68.7% | 71.9% | 70.7% | 69.9% | 70.7% | 71.8% | 70.8% |
| 研發費用 | 62.9M | 67.9M | 71.6M | 67.6M | 68.8M | 70.0M | 72.4M | 76.8M | 81.4M | 89.9M | 84.3M | 87.3M |
| 銷售管理費用 | 104M | 102M | 108M | 103M | 108M | 113M | 114M | 110M | 112M | 109M | 116M | 126M |
| 營業利益 | −37.1M-32% | −61.8M-49% | −36.0M-19% | −52.0M-94% | −54.4M-38% | −121M+244% | −44.4M-31% | −841M+1074% | −87.1M | −35.1M | −64.7M | −71.6M |
| 營業利益率 | -6.1% | -10.1% | -5.6% | -8.3% | -8.6% | -19.2% | -6.9% | -130.9% | -13.5% | -5.3% | -9.8% | -11.0% |
| 稅後淨利 | −38.9M+19% | −63.8M-31% | −25.1M-24% | −49.5M-94% | −32.7M-60% | −93.0M+222% | −33.3M-42% | −838M+1185% | −81.9M | −28.9M | −57.1M | −65.2M |
| 淨利率 | -6.4% | -10.4% | -3.9% | -7.9% | -5.2% | -14.8% | -5.2% | -130.4% | -12.7% | -4.4% | -8.6% | -10.0% |
| 稀釋 EPS | -0.21+11% | -0.36-32% | -0.14-26% | -0.28-94% | -0.19-61% | -0.53+212% | -0.19-46% | -4.92+1130% | -0.49 | -0.17 | -0.35 | -0.40 |
| 稀釋股數 | 181M | 179M | 176M | 177M | 176M | 174M | 171M | 170M | 168M | 165M | 165M | 164M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 774M | 751M | 781M | 726M | 680M | 1.2B | 1.2B | 1.2B | 1.1B | 1.1B | 1.0B | 959M |
| 應收帳款 | 221M | 214M | 193M | 211M | 225M | 233M | 212M | 218M | 214M | 217M | 206M | 215M |
| 存貨 | 28.8M | 31.6M | 38.2M | 39.9M | 38.2M | 38.0M | 37.0M | 34.9M | 32.3M | 29.5M | 35.9M | 34.1M |
| 總資產 | 2.8B | 2.8B | 2.9B | 2.9B | 2.9B | 3.4B | 3.5B | 3.5B | 4.3B | 4.4B | 4.3B | 4.3B |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 1.4B | 1.5B | 1.5B | 1.5B | 1.5B | 2.0B | 2.0B | 2.0B | – | 2.1B | – | – |
| 股東權益 | 1.3B | 1.3B | 1.4B | 1.4B | 1.4B | 1.4B | 1.5B | 1.5B | 2.3B | 2.3B | 2.3B | 2.3B |
| 負債比 | 52.5% | 52.4% | 51.5% | 51.6% | 50.9% | 58.6% | 57.3% | 57.4% | – | 47.0% | – | – |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 9.5M-40% | – | – | – | 15.9M | – | – | 8.9M | – | – | – |
| 資本支出 | – | 1.7M | – | – | – | 2.7M | – | – | 1.1M | – | – | – |
| 自由現金流 | – | 7.9M-40% | – | – | – | 13.2M | – | – | 7.8M | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | 94.3M | 75.5M |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | 1.3% | – | – | – | 2.1% | – | – | 1.2% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 2.5B
| Teladoc Health Integrated Care | 1.6B | 62.4% | +3.3% |
|---|---|---|---|
| Better Help | 950M | 37.6% | -8.7% |
地區2025 年度 · 2.5B
| 美國 | 2.1B | 81.9% | -4.1% |
|---|---|---|---|
| 美國以外 | 458M | 18.1% | +11.9% |
產品／服務2025 年度 · 2.5B
| Access Fees Revenue | 2.1B | 82.7% | -5.6% |
|---|---|---|---|
| 其他 | 438M | 17.3% | +23.6% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 2.5B | -1.5% | −200M | -7.9% | -1.14 | 285M |
| FY2024 | 2.6B | -1.3% | −1.0B | -39.0% | -5.87 | 283M |
| FY2023 | 2.6B | +8.1% | −220M | -8.5% | -1.34 | 339M |
| FY2022 | 2.4B | +18.4% | −13.7B | -567.5% | -84.60 | 173M |
| FY2021 | 2.0B | +85.8% | −429M | -21.1% | -2.73 | 185M |
| FY2020 | 1.1B | +97.7% | −485M | -44.3% | -5.36 | −57.5M |
| FY2019 | 553M | +32.4% | −98.9M | -17.9% | -1.38 | 26.4M |
| FY2018 | 418M | – | −97.1M | -23.2% | -1.47 | −8.9M |